Pulmonx (LUNG) Amortization of Deferred Charges (2019 - 2025)
Pulmonx has reported Amortization of Deferred Charges over the past 7 years, most recently at $100000.0 for Q3 2025.
- Quarterly Amortization of Deferred Charges changed 0.0% to $100000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $211000.0 through Sep 2025, down 7.86% year-over-year, with the annual reading at $52000.0 for FY2024, 8.33% up from the prior year.
- Amortization of Deferred Charges was $100000.0 for Q3 2025 at Pulmonx, roughly flat from $100000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $100000.0 in Q2 2021 and troughed at $10000.0 in Q4 2022.
- The 5-year median for Amortization of Deferred Charges is $100000.0 (2021), against an average of $63000.0.
- Year-over-year, Amortization of Deferred Charges crashed 83.0% in 2021 and then skyrocketed 60.0% in 2024.
- A 5-year view of Amortization of Deferred Charges shows it stood at $17000.0 in 2021, then tumbled by 41.18% to $10000.0 in 2022, then grew by 30.0% to $13000.0 in 2023, then dropped by 15.38% to $11000.0 in 2024, then skyrocketed by 809.09% to $100000.0 in 2025.
- Per Business Quant, the three most recent readings for LUNG's Amortization of Deferred Charges are $100000.0 (Q3 2025), $100000.0 (Q2 2025), and $11000.0 (Q4 2024).